Table 1.
Patient characteristics.
| Patient Characteristics | Value 1 |
|---|---|
| General | |
| Age, years | 57.8 (45–71.2) |
| Female sex | 93 (48%) |
| NYHA class ≥ III 2 | 65 (38%) |
| 6 min walking distance, m | 438 (306–530) |
| NT-proBNP, pg/mL | 323 (117–864) |
| Hemodynamics | |
| mPAP, mmHg | 27 (19–42) |
| PVR, dyn/s/cm−5 | 252.5 (150–542) |
| Physiological data | |
| Ea, mmHg/mL | 0.52 (0.33–0.91) |
| Ees, mmHg/mL | 0.29 (0.22–0.43) |
| Ees/Ea ratio | 0.57 (0.37–0.84) |
| CMR strain | |
| GLS, % | −16.7 ± 5.5 |
| GCS, % | −12.1 ± 3.9 |
| CMR volumetry | |
| RV EDVi, mL/m2 | 77.1 (62–96.9) |
| RV ESVi, mL/m2 | 44.6 (35.8–60.1) |
| RV SVi, mL/m2 | 27.4 (21.6–34.8) |
| RV EF, % | 37 (27–46) |
| RVMASS, g | 53 (21–81.3) |
1 Values given as number (%), mean ± SD, or median (IQR); 2 Abbreviations: CMR, cardiac magnetic resonance; Ea, pulmonary arterial end-systolic pressure/volume ratio; EDVi, end-diastolic volume indexed to body surface area; Ees, right ventricular end-systolic pressure/volume ratio; EF, ejection fraction; ESVi, end-systolic volume indexed to body surface area; GCS, global circumferential strain, GLS, global longitudinal strain; mPAP, mean pulmonary artery pressure; NT-proBNP, N-terminal fragment of pro-brain natriuretic peptide; NYHA, New York Heart Association; PVR, pulmonary vascular resistance; RV, right ventricle; RVMASS, right ventricular mass; SVi, stroke volume indexed to body surface area.